LATIN AMERICA injectable oral contraceptives , nutritional products , lyophilized , cytotoxic , suppositories , liquids , antiretrovirals , semi-solid and active ingredients .
Under constant renovations of medical solutions , the company allocates part of its capital to research and development , hoping that by mid 2017 , the Latin American market could enjoy new products in cardiology , infant and critical care .
“ Today we have this package for infant formulas , which we will launch in the next 24 months . On the side of Pharma , we will draw the market for critical drug medicine and cardiology ,” said Sosa .
Aspen Labs Latin American CEO said : “ We will be launching new solutions in some countries , this to complement our female care and cardiovascular health business units .” Additionally , they will continue to work on alternatives for those mothers who are not able to produce breast milk , adding new formulas to its portfolio in this category , such objectives include :
“ We firmly believe that adding value requires full conviction , is not only to sell products , but integrating shareholder value , by having an important responsibility with our society ”
– Carlos Abelleyra , CEO of Aspen Labs in Latin America ( except Brazil )
1 . Innovative formulas for breast milk reproduction during the baby ’ s development .
2 . New products intended for infant development during gestation and growth .
www . aspenlabs . com . mx 87